Miami Neuroscience Institute Update on Alzheimer’s Disease
Overview
In this online course, learners will complete an in-depth exploration of Alzheimer's Disease, tracing its historical timeline and key milestones, analyzing recent advances in diagnosis and treatment, and understanding the implications of cutting-edge clinical trial data. Learners will also delve into the mechanisms of monoclonal antibodies, learn to apply patient selection criteria effectively and discuss practical strategies for implementing these treatments in clinical practice. This program is designed to keep learners at the forefront of Alzheimer's research and treatment, enhancing their expertise and patient care.
Commercial Supporter
Baptist Health gratefully acknowledges the commercial support provided by Boston Scientific, Cerenovus, Eisai, Medtronic, Terumo Neuro, and Supernus Pharmaceuticals for the Miami Neuroscience Institute Update on Alzheimer’s Disease course.
Target Audience
Neurologists, Neurosurgeons, Neuroradiologists, Diagnostic Radiologists, Emergency Medicine Physicians, Internal Medicine Physicians, Family Physicians, General Internists, Physician Assistants/Physician Associates, Psychiatrists, Critical Care and Neuroscience Nurses, Neurosurgery Nurses, Nurse Practitioners, Respiratory Therapists, Clinical Pharmacists, Pharmacy Technicians and Clinical Neurophysiology Technicians.
Learning Objectives
- Describe the historical timeline of Alzheimer’s Disease and analyze key milestones.
- Explain advances in diagnosis and treatment and implications of recent research findings from clinical trial date.
- Explain the mechanism of action of monoclonal antibodies against Alzheimer’s disease.
- Utilize patient selection criteria appropriately for monoclonal antibody therapy.
- Discuss the implementation of these treatments in clinical practice.
Faculty
Victor Faradji, M.D., FAAN
Founding Member, and Board of Directors Member
First Choice Neurology
Baptist Health Quality Network
Miami, Florida
G. Peter Gliebus, M.D.
Medical Director, Cognitive and Behavioral Program
Marcus Neuroscience Institute
Associate Professor of Neurology
Florida Atlantic University, Charles E. Schmidt College of Medicine
Boca Raton, Florida
Michael McDermott, M.D.
Chief Medical Executive
Irma & Kalman Bass Endowed Chair in Clinical Neuroscience
Miami Neuroscience Institute
Chief of the Division of Neuroscience and Professor of Translational Medicine
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
Planners
Diego Torres-Russotto, M.D.
Chair of Neurology, Chief of Movement Disorders
Director, Neurology Residency Program
Miami Neuroscience Institute
Adjunct Professor, Department of Neurological Sciences
University of Nebraska Medical Center
Clinical Professor
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
Jamelah Morton, Ph.D., APRN, ACNP-BC, CCRN, CNRN, SCRN
Neurosurgery Advanced Practice Provider Manager
Miami Neuroscience Institute
Miami, Florida
Victor Faradji, M.D., faculty for this educational activity, receives research support from Eisai, Novo Nordisk, Eli Lilly and Acadia.
G. Peter Gliebus, M.D., faculty for this educational activity, is on the Speakers’ Bureau for Eisai and has indicated that his presentation or discussion will not include off-label or unapproved product usage.
Michael McDermott, M.D., director and faculty for this educational activity, is a consultant for Deinde Medical, Stryker, Insightec, ZAP Surgical and Light Helmets.
Diego Torres-Russotto, M.D., is a consultant for AbbVie, Acorda, Ipsen, Neurocrine, Revance, Sunovion and Teva; is on the speakers’ bureau for AbbVie, Acorda, Ipsen, Neurocrine and Teva; and receives grant support from Ipsen, Merz and Revance.
Jamelah Morton and all other individuals involved in the planning, development, review, presentation, authoring and/or editing of the symposium content do not have relevant financial relationships with ineligible companies.
All financial relationships have been mitigated.
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Available Credit
- 1.00 ABIM Medical Knowledge
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy
Register/Take course
Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Required Hardware/Software


Mobile Users
This site is supported on the following mobile devices:
- Apple iOS mobile devices running iOS 10 or later
- Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox

Technical Support
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.